Radioimmunotherapy and colorectal cancer
M. Koppe, R. Bleichrodt, W. Oyen and O. BoermanArticles
BJS
2005
264--276
Lack of efficacy of two consecutive treatments of radioimmunotherapy with 131I-cG250 in patients with metastasized clear cell renal cell carcinoma
A. Brouwers, P. Mulders, P. de Mulder, W. van den Broek, W. Buijs, C. Mala, F. Joosten, E. Oosterwijk, O. Boerman, F. Corstens and W. OyenArticles
JCO
2005
6540--6548
Antibody-guided radiation therapy of cancer
M. Koppe, E. Postema, F. Aarts, W. Oyen, R. Bleichrodt and O. BoermanArticles
Cancer Metastasis Rev
2005
539--567
Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines
E. Troost, J. Bussink, J. Kaanders, J. van Eerd, J. Peters, P. Rijken, O. Boerman and A. van der KogelArticles
RTO
2005
194--199
FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis
M. van Kouwen, J. Jansen, H. van Goor, S. de Castro, W. Oyen and J. DrenthArticles
EJNMMI
2005
399--404
FDG-PET in the detection of early pancreatic cancer in a BOP hamster model
M. van Kouwen, P. Laverman, J. van Krieken, W. Oyen, J. Jansen and J. DrenthArticles
NUCMB
2005
445--450
2-(18F)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study
M. van Kouwen, F. Nagengast, J. Jansen, W. Oyen and J. DrenthArticles
JCO
2005
3713--3717
Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of 99mTc labelled epidermal growth factor
B. Cornelissen, V. Kersemans, I. Burvenich, R. Oltenfreiter, J. Vanderheyden, O. Boerman, C. Vandewiele and G. SlegersArticles
NUCMC
2005
147--153
Application of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes for gene transfer into human ovarian carcinoma cells
F. Verbaan, P. Klein Klouwenberg, J. van Steenis, C. Snel, O. Boerman, W. Hennink and G. StormArticles
IJPHA
2005
185--192
Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET
H. van Laarhoven, L. de Geus-Oei, B. Wiering, J. Lok, M. Rijpkema, J. Kaanders, P. Krabbe, T. Ruers, C. Punt, A. van der Kogel, W. Oyen and A. HeerschapArticles
Radiology
2005
181--188
Value of fluorodeoxyglucose positron emission tomography in women with breast cancer
M. Landheer, M. Steffens, J. Klinkenbijl, A. Westenberg and W. OyenArticles
BJS
2005
1363--1367
Optimised PET reconstruction of the head and neck area: improved diagnostic accuracy
W. Vogel, B. Wensing, J. van Dalen, P. Krabbe, F. van den Hoogen and W. OyenArticles
EJNMMI
2005
1276--1282
Colorectal cancer: the role of PET/CT in recurrence
W. Vogel, B. Wiering, F. Corstens, T. Ruers and W. OyenArticles
CANI
2005
S143--S149
Imaging of infection and inflammation with an improved 99mTc-labeled LTB4 antagonist
J. van Eerd, M. Broekema, T. Harris, D. Edwards, W. Oyen, F. Corstens and O. BoermanArticles
JNM
2005
1546--1551
Scintigraphic imaging of infectious foci with an 111In-LTB4 antagonist is based on in vivo labeling of granulocytes
J. van Eerd, W. Oyen, T. Harris, H. Rennen, D. Edwards, F. Corstens and O. BoermanArticles
JNM
2005
786--793
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy
I. de Vries, W. Lesterhuis, J. Barentsz, P. Verdijk, J. van Krieken, O. Boerman, W. Oyen, J. Bonenkamp, J. Boezeman, G. Adema, J. Bulte, T. Scheenen, C. Punt, A. Heerschap and C. FigdorArticles
NATUREBT
2005
1407--1413
The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases
B. Wiering, P. Krabbe, G. Jager, W. Oyen and T. RuersArticles
Cancer
2005
2658--2670
CCK-2/gastrin receptor-targeted tumor imaging with (99m)Tc-labeled minigastrin analogs
B. Nock, T. Maina, M. Béhé, A. Nikolopoulou, M. Gotthardt, J. Schmitt, T. Behr and H. MäckeArticles
JNM
2005
1727--1736
Discriminating infection from sterile inflammation: can radiolabelled antibiotics solve the problem?
W. Oyen, F. Corstens and O. BoermanArticles
EJNMMI
2005
151--152